4//SEC Filing
Morrone Louis H. 4
Accession 0001104659-23-077919
CIK 0000001800other
Filed
Jul 4, 8:00 PM ET
Accepted
Jul 5, 11:55 AM ET
Size
9.8 KB
Accession
0001104659-23-077919
Insider Transaction Report
Form 4
Morrone Louis H.
EXECUTIVE VICE PRESIDENT
Transactions
- Award
Common shares without par value
2023-06-30+1,815→ 55,471 total - Tax Payment
Common shares without par value
2023-07-01$109.02/sh−556$60,615→ 54,915 total - Award
Option (right to buy)
2023-06-30+7,100→ 7,100 totalExercise: $108.52From: 2024-06-30Exp: 2033-06-29→ Common Shares (7,100 underlying)
Holdings
- 2,481(indirect: By Trust)
Common shares without par value
Footnotes (3)
- [F1]These shares represent a performance-based restricted stock award under the Abbott Laboratories 2017 Incentive Stock Program. The award has a 3-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The award includes the right to have shares withheld for tax purposes.
- [F2]Balance in the Abbott Laboratories Stock Retirement Trust as of June 30, 2023.
- [F3]Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 2,366 on June 30, 2024, 2,367 on June 30, 2025, and 2,367 on June 30, 2026.
Documents
Issuer
ABBOTT LABORATORIES
CIK 0000001800
Entity typeother
Related Parties
1- filerCIK 0001867666
Filing Metadata
- Form type
- 4
- Filed
- Jul 4, 8:00 PM ET
- Accepted
- Jul 5, 11:55 AM ET
- Size
- 9.8 KB